IRWD IRONWOOD PHARMACEUTICALS INCcompanySEC Filings & Insider Trading Activity 2026
Latest IRONWOOD PHARMACEUTICALS INC (IRWD) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on February 26, 2026, a 10-Q quarterly report filed on May 7, 2026, an 8-K current report filed on August 6, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for IRONWOOD PHARMACEUTICALS INC (IRWD) (SEC CIK 1446847), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on IRONWOOD PHARMACEUTICALS INC
Ask AI about IRWD filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting IRWD positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on IRWD.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of IRONWOOD PHARMACEUTICALS INC (IRWD) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Aug 6, 2026 | - | - | - |
8-K | Jun 18, 2026 | - | - | - |
8-K | Jun 15, 2026 | - | - | - |
8-K | May 21, 2026 | - | - | |
8-K | May 13, 2026 | - | - | |
10-Q | May 7, 2026 | Mar 31, 2026 | - | |
8-K | May 7, 2026 | - | - | |
8-K | Mar 11, 2026 | - | Analysis | - |
10-K | Feb 26, 2026 | Dec 31, 2025 | - | |
8-K | Feb 25, 2026 | - | Analysis | - |
8-K | Jan 2, 2026 | - | - | |
8-K | Dec 23, 2025 | - | - | |
8-K | Nov 26, 2025 | - | - | |
10-Q | Nov 10, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 11, 2025 | Jun 30, 2025 | - | |
10-Q | May 12, 2025 | Mar 31, 2025 | - | |
10-K | Mar 31, 2025 | Dec 31, 2024 | - | |
SC 13G | Nov 14, 2024 | - | - | |
10-Q | Nov 7, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | - | |
10-Q | May 9, 2024 | Mar 31, 2024 | - | |
10-K | Feb 16, 2024 | Dec 31, 2023 | - | |
10-Q | Nov 9, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 9, 2023 | Jun 30, 2023 | - | |
SC 13D | Jul 7, 2023 | - | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate IRWD share value held by 13F filers tracked by SignalX, by quarter.
- State Street Corp+3.05M (+69%)
- Two Sigma Investments+3.00M (+105%)
- AQR Capital Management+2.81M (+60%)
- Dimensional Fund Advisors+1.75M (+529%)
- Goldman Sachs Group+1.42M (+111%)
- Bank of America Corp2.84M (-25%)
- Renaissance Technologies LLC143.9K (-2%)
- Wells Fargo & Co117.7K (-67%)
- Raymond James Financial105.9K (-12%)
- Millennium Management103.6K (-18%)
- Franklin Resources+744.6K
- Fifth Third Bancorp+165.1K
- Principal Financial Group+11.4K
- Vanguard Group Inc−15.96M
- Invesco Ltd−449.2K
- JPMorgan Chase & Co−214.6K
Source: 13F-HR filings on SEC EDGAR (aggregated from 183 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest IRWD SEC filings in 2026?
IRONWOOD PHARMACEUTICALS INC (IRWD) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on May 7, 2026, an 8-K current report on August 6, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did IRWD file its most recent 10-K annual report?
IRONWOOD PHARMACEUTICALS INC (IRWD) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view IRWD 10-Q quarterly reports?
IRONWOOD PHARMACEUTICALS INC (IRWD)'s most recent 10-Q quarterly report was filed on May 7, 2026. SignalX displays every IRWD 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has IRWD filed recently?
IRONWOOD PHARMACEUTICALS INC (IRWD)'s most recent 8-K was filed on August 6, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find IRWD insider trading activity (Form 4)?
SignalX aggregates every IRWD Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does IRWD file with the SEC?
IRONWOOD PHARMACEUTICALS INC (IRWD) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new IRWD filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for IRONWOOD PHARMACEUTICALS INC (IRWD).
What is IRWD's SEC CIK number?
IRONWOOD PHARMACEUTICALS INC (IRWD)'s SEC CIK (Central Index Key) number is 1446847. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1446847 to look up all IRWD filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of IRONWOOD PHARMACEUTICALS INC SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 73+ filings.